Liberty Square Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$972K Buy
810
+19
+2% +$19.4K 0.23% 49
2026
Q1
$728K Buy
791
+1
+0.1% +$1.01K 0.2% 54
2025
Q4
$849K Sell
790
-50
-6% -$47.8K 0.24% 52
2025
Q3
$641K Hold
840
0.2% 68
2025
Q2
$655K Buy
840
+114
+16% +$88.6K 0.23% 63
2025
Q1
$600K Buy
726
+22
+3% +$18.3K 0.23% 68
2024
Q4
$594K Buy
+704
New +$583K 0.22% 70

Other funds holding LLY

Liberty Square Wealth Partners's LLY Position: Q2 2026 in Review

Liberty Square Wealth Partners increased its Eli Lilly (LLY) stake by 2.4% in Q2 2026, buying an estimated $19.4K and bringing the position to 810 shares worth $972K. The position accounts for 0.23% of the portfolio, ranked #49.

Liberty Square Wealth Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Liberty Square Wealth Partners held 810 shares of Eli Lilly worth $972K as of Q2 2026.
  • Liberty Square Wealth Partners bought 19 Eli Lilly shares in Q2 2026, an estimated $19.4K.
  • Eli Lilly made up 0.23% of Liberty Square Wealth Partners's portfolio in Q2 2026, its #49 holding.
  • Liberty Square Wealth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Liberty Square Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.